Supplementary Data from VERONICA: Randomized Phase II Study of Fulvestrant and Venetoclax in ER-Positive Metastatic Breast Cancer Post-CDK4/6 Inhibitors – Efficacy, Safety, and Biomarker Results

Authors :: Aditya Bardia
Aulde Flechais
Timothy R. Wilson
Kushagra Gupta
Rupal Desai
Ching-Wei Chang
Gianfilippo Bertelli
Catherine Shannon
Anne Armstrong
Steve McCune
Frances Boyle
Thomas Decker
Xinni Song
Katarzyna J. Jerzak
Rebecca Bowen
Tharu M. Fernando
Geoffrey J. Lindeman
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Supplementary Data from VERONICA: Randomized Phase II Study of Fulvestrant and Venetoclax in ER-Positive Metastatic Breast Cancer Post-CDK4/6 Inhibitors – Efficacy, Safety, and Biomarker Results

Tools